NOT KNOWN FACTS ABOUT PHENOBARBITAL SODIUM INJECTION DAILYMED

pentobarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Carefully. Coadministration of CYP3A4 inducers may well reduce sufentanil ranges and efficacy, probably precipitating withdrawal syndrome in patients who have produced Actual physical dependence to sufentanil. Discontinu